Clinical Trial Update: Psilocybin for Prolonged Grief Disorder [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is recruiting to evaluate psilocybin for Prolonged Grief Disorder at the University of Virginia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prolonged Grief Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: University of Virginia | Conditions: Prolonged Grief Disorder | EARLY_Phase 1 | Status: RECRUITING